Share Buyback Transaction Details September 25 – October 1, 2025 PRESS RELEASE Share Buyback Transaction Details September 25 – October 1, 2025 Alphen aan den Rijn – October 2, 2025 - Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 345,700 of its own ordinary shares in the period from September 25, 2025, up to and including October 1, 2025, for €39.3 million and at an average share price of €113.63. These repurchases are part of the share buyback pro...
In this October update of our Dynamic Top Pick List we are removing VGP while adding Shurgard and Wolters Kluwer. Since its recent inclusion in our Dynamic Top Pick List in July-25, VGPs share rose by 10.6%. While we still believe there is significant upside to the share price, we don't see short term catalysts. In fact, the macro picture remains cloudy with the jury still out on the impact of tariffs and the erratic US policy shifts. Also, we are a bit concerned that competition in Western Eur...
Last year Wolters Kluwer's share saw an incredible performance based on the one hand from it's stable & predictable business in a volatile environment, and on the other hand from the upside that AI can bring to the business. Since the announcement of the retirement of CEO Nancy McKinstry, there has been a lot of negative sentiment surrounding Wolters Kluwer. Since its all-time high mid-February, the stock is down 37% this year. While the AI hype in the beginning of this year brought the WKL sh...
Aedifica, Cofinimmo: Update on the Belgian Competition Authority. Arcadis: Share buyback programme. ASR: Focus on rural Real Estate – Farmland Fund. Coca-Cola Europacific Partners plc: Disasters strike. Heineken: From green to red. Zabka: Raising medium term store opening guidance
Aedifica provided an update on its pending transaction, confirming that it remains in the pre-notification phase with the Belgian Competition Authority (BCA). The company is in ongoing discussions with the BCA's Investigation and Prosecution Service (IPS), including around potential commitments such as asset disposals in Belgium. While the timeline for the formal filing has shifted, Aedifica still aims to launch the exchange offer in Q4 2025, subject to ending the pre-notification phase by end-O...
Inventiva Appoints Andrew Obenshain as Chief Executive Officer Daix (France), New York City (New York, United States), October 1, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced the appointment of Andrew Obenshain as Chief Executive Officer (“CEO”) of the Company. Mr. Obenshain will also join the Company’s Board of Directors. He succeeds Frédéric Cren, the Company’s co-founder...
Inventiva annonce la nomination d’Andrew Obenshain au poste de Directeur Général Daix (France), New York City (New York, Etats-Unis), le 1er octobre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de thérapies orales pour le traitement de la stéatohépatite associée à un dysfonctionnement métabolique (« MASH »), annonce aujourd’hui la nomination d’Andrew Obenshain au poste de Directeur Général, à compter du 1er octobre 2025. M. Obenshain rejoindra également le Conseil d’administration de la Socié...
Over the past month, the EPRA BELUX index has underperformed (total return) the EPRA Developed Europe index by 3.2%, the STOXX50 by 5.4%, and the BEL20 by 3.6%. This underperformance relative to the EPRA Developed Europe Index can be attributed to the stronger performance of UK real estate compared to eurodenominated stocks, as UK equities led the recovery following a selloff in August. Additionally, the BELUX region had already posted strong year-to-date performance, which limited further upsid...
JDE Peet’s calls for coffee industry to implement Regenerative Agriculture Coffee Roadmap to boost coffee supply chain resilience Call to action comes as company marks 10 years of its leading Common Grounds farmer programmes PRESS RELEASE Amsterdam, October 1, 2025 This International Coffee Day, JDE Peet’s (EURONEXT: JDEP) celebrates ten years of its pioneering Common Grounds farmer programmes and calls on the coffee industry to urgently implement the , securing the future of coffee. The call to action comes as global coffee supplies have been hit by worsening climate conditions, includi...
Inventiva reported 1H25 results which hold no surprises, and confirmed its cash runway guidance to the end of 3Q26 and timeline for the topline readout from the phase 3 (NATiV3) trial of lanifibranor in MASH, which continues to be guided for 2H26. We believe this readout is de-risked by strong phase 2b data, and with oral dosing and clean safety (limited GI side effects), lanifibranor is well positioned to capture a meaningful share of the validated MASH commercial opportunity. Given relative un...
Inventiva reports its unaudited 2025 first-half financial results and provides a corporate update Cash and cash equivalents at €146.7 million including €24.6 million in short-term deposits1 as of June 30, 2025Receipt of the gross proceeds of €115.6 million from the second tranche of the structured financing of up to €348 million2, following in particular the completion in April 2025 of enrolment of the Phase 3 clinical trial NATiV3 evaluating lanifibranor in patients with MASHCash runway currently planned until the end of the third quarter of 2026Revenues of €4.5 million recorded in the ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.